A federal judge orders the Trump administration to explain a reported discrepancy between Pete Hegseth’s proposed testosterone screening and treatment plan for some male troops and the handling of hormone care for transgender service members. The administration says it will check male service members age 30 and older to confirm they have “right testosterone levels” for military performance and will consider treatment for those found to have low testosterone. The judge’s questions focus on why the policy appears to permit testosterone replacement therapy (TRT) for cisgender men with deficiencies while denying hormone treatment to transgender troops. Multiple reports say the judge is seeking clarification about the medical rationale and consistency of the approach, referencing differences in how hormone-related care is applied across troop categories. The court order requires the administration to provide an explanation for the contrast between the testosterone initiative and the existing transgender care restrictions. The matter is under judicial review as the government prepares its response.